Old Web
English
Sign In
Acemap
>
authorDetail
>
Anthony Jaslowski
Anthony Jaslowski
University of Wisconsin-Madison
Medicine
Immunology
Chemotherapy
Chemotherapy regimen
Rituximab
3
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Intensive Induction Chemotherapy
2019
Blood
Geoffrey L. Uy
Jun Yin
Heidi D. Klepin
Shira Dinner
Anthony Jaslowski
Stephen A. Strickland
Jane L. Liesveld
John C. Byrd
Richard Stone
Show All
Source
Cite
Save
Citations (2)
Phase II Study of Modified Hyper-CVAD with Rituximab Maintenance for Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
2004
Blood
Brad S. Kahl
James McGovern
Jules Blank
Anthony Jaslowski
Gerald Bayer
Wayne A. Bottner
Hamied Rezazadeh
Thomas McFarland
David Hei
Jamie Smith
Emily A. Stevens
Jens C. Eickhoff
Walter L. Longo
Show All
Source
Cite
Save
Citations (10)
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer
2003
Lung Cancer
Tien Hoang
KyungMann Kim
Anthony Jaslowski
Paul L. Koch
Peter A. Beatty
James McGovern
Maria Quisumbing
Gary Shapiro
Robert S. Witte
Joan H. Schiller
Show All
Source
Cite
Save
Citations (46)
1